Wednesday, October 16, 2024

De Novo Hepatitis B Prophylaxis in Pediatric Recipients of Hepatitis B Core Antibody-Positive Living Donor Liver Grafts

 

De Novo Hepatitis B Prophylaxis in Pediatric Recipients of Hepatitis B Core Antibody-Positive Living Donor Liver Grafts

Introduction

Liver transplantation (LT) is the only cure for end-stage pediatric liver disease. In spite of the fact that good long-term outcome has been achieved in pediatric recipients, many questions still remain unanswered. One of the unsolved issues is the long-term prevention and management of de novo hepatitis B virus (HBV) infection (DNHB) [1]. The use of hepatitis B core antibody positive (HBcAb +ve) liver grafts is a promising strategy to expand the donor pool, however, the potential risk of DNHB is one of the major concerns of using this type of liver grafts. So far, the experience of using HBcAb +ve grafts in pediatric LT is limited [2]. Several different approaches for DNHB prophylaxis have been used in recipients of HBcAb +ve livers according to the preference and experience of each institution. These include nucleos(t)ide analogues (NUCs), hepatitis B immunoglobulin (HBIg) or a combination of both [3] and HBV vaccination [4]. We describe our experience in the management of 2 pediatric HBV naïve recipients of HBcAb +ve liver grafts from living donors, who are following at Dr. Yassin Abdel Ghaffar Charity Center for Liver Disease and Research in Egypt.

Case 1

A male child, HH, who was referred to us at the age of 5.6 years for LT. He was diagnosed with homozygous familial hypercholesterolemia. His cholesterol level was persistently above 700 mg% in spite of medical treatment. His sister died at age of 6 years with the same condition. Both of his parents had hypercholesterolemia so they were not suitable for graft donation. The only available donor was his uncle, who during LT work-up was found to be HBcAb +ve but HBsAg –ve, HBsAb –ve and HBV DNA –ve. He was otherwise completely suitable for donation. The preoperative work up and donor data are presented in Tables 1 & 2. HH underwent LT on 16.6.2016. Our prophylactic regimen against DNHB involved preoperative, intraoperative, and postoperative prophylactic work up.

biomedres-openaccess-journal-bjstr

Table 1: Pre-operative work up of both recipients.

Note: AST: Aspartate Transaminase; ALT: Alanine Transaminase BMI: Body Mass Index; cm: centimeter; CMV: Cytomegalovirus; CT: Computed Tomography; EBV: Ebestien Bar Virus; ECHO: Electrocardiography; Hb: Hemoglobin; HBcAb: Hepatitis B Core Antibody; HBV: Hepatitis B virus, HBsAb: Hepatitis B Surface Antibody; HCV-Ab; Hepatitis C Virus-Antibody; Ig: Immunoglobulin; Kg: Kilogram; LT: liver Transplantation; PCR: Polymerase Chain Reaction; PET: Positron Emission Tomography; TLC: Total Leucocyte Count

biomedres-openaccess-journal-bjstr

Table 2: Data of the donors of both cases.

Pre-Operative

HH had received HBV vaccine in infancy as part of the national vaccination program. His HBsAb titer before LT was zero. Two booster doses of the vaccine were given aiming at HBsAb titer of 1000 IU/L. The patient reached the target titer before LT

Intraoperative

50 IU/kg HBIg through intramuscular (IM) route were given during a hepatic phase.

Post-Operative

In the first week: HBIg was given daily for 4 days aiming at keeping the HBsAb titer above 1000 IU/L. Lamivudine at dose of 3 mg/kg/day was started on day 1 post-LT. In the first year postoperative: both Lamivudine and HBIg were used. HBsAb titer was monitored every 2 weeks in the first 3 months then monthly thereafter until the end of the first year post-LT aiming to maintain HBsAb level above 200 IU/L. A dose of 200 IU HBIg was given if the HBsAb level fell below 200 IU/L. Five more such doses of HBIg were needed in the first year post-LT to maintain the target HBsAb titer. HBcAb, HBV DNA and HBsAg were assessed every 2 to 3 months so long liver enzymes were normal but at any time they increased. In the second year post-LT we stopped both lamivudine and HBIg and gave only HBV vaccine. A double dose vaccine was given only once. Since then and up till now he needed no more doses as his HBsAb titer has been always maintained above 1000 IU/L. Follow up for HBsAb titer, HBsAg, HBcAb and HBV DNA is done every 3 months.

Immunosuppressive Regimen

HH received methylprednisolone 10 mg/kg intra-operatively then changing to 2 mg/kg/day oral prednisone and tapering it to complete withdrawal after 3 months. Maintenance immunosuppression was with tacrolimus and mycophenolate mofetil. HH cholesterol level had dropped markedly after LT but it did not reach the normal level. So he was put on statins. Since then his cholesterol was normal most of time. On his last visit on 21.2.2021 all his HBV markers were negative. His HBsAb titer was > 1000 IU/L.

Case 2

Male patient, MA, 15.5 years old, had recurrent hepatoblastoma and was referred to our center for LT. He was diagnosed at the age of 12 years to have hepatoblastoma. Left hepatectomy was done and he received chemotherapy. At the age of 14 years, tumor recurrence occurred, and MA had undergone resection for segment V plus cholecystectomy and received chemotherapy. One year later, at age of 15 years, tumor recurrence occurred again, and he received 2 doses of chemotherapy. Then he was referred for salvage LT.The only available donor was his father who was discovered during donor pre-operative work up to be HBcAb+ve but negative for HBsAg, HBsAb and HBV DNA. With the lack of another suitable donor and the need for urgent LT because of the bad condition of the recipient and the aggressiveness and frequent recurrences of the tumor, we had to accept the father as a donor. Pre-operative assessment and donor data are summarized in Tables 1 & 2. The patient underwent LT on 15.1.2018. A strict prophylactic regimen was followed. Pre-operative: MA had also received HBV vaccine in infancy as part of the national vaccination program but the HBsAb titer was found to be <2 IU/L. After double adult dose HBV vaccine, the HBsAb reached 704.7 IU/L. With his immunosuppressed state and the urgency of LT in this case, we couldn’t wait till the target pre-operative HBsAb titer (1000 IU/L) was reached.

Intraoperative

The recipient was injected with 50 IU/kg HBIg through IM route during the anhepatic phase.

First Post-Operative Week

MA had received HBIg daily for 4 days aiming at keeping the HBsAb titer above 1000 IU/L. Oral Entecavir at dose of 0.015 mg/ kg/day was started on day 1 post-LT.

In the First Postoperative Year

Both Entecavir and HBIg were used. Monitoring of HBsAb titer and the other HBV markers was as in case 1. A dose of 540 IU HBIg was given if the HBsAb level fell below 200 IU/L. Seven more doses of HBIg were required in the first year post-LT to maintain the target HBsAb titer. According to the decision of the oncologists he received 2 cycles of chemotherapy 1.5 months after LT.

On the Second Year Post-LT

Entecavir and HBIg were discontinued, and the patient received double adult HBV vaccine dose only once. He was lost to follow up 1.5 years post-LT.

Immunosuppressive Regimen

MA received methylprednisolone 10 mg/kg intraoperative, then 2 mg/kg/day prednisolone tapering it to complete withdrawal after 1 year. Maintenance immunosuppression was with tacrolimus monotherapy. One-year post-LT a recurrent hepatic focal lesion and bilateral pulmonary nodules appeared and he started palliative treatment. On his last visit on 13.1.2020 all his HBV markers were negative. His HBsAb titer was >1000 IU/L. Sadly, he passed away 2 years after LT.

Discussion

The reported incidence of DNHB infection among patients receiving HBcAb +ve grafts is unacceptably high without prophylaxis (38%-100%) as such grafts carry a high risk of occult HBV infection (defined as detectable intrahepatic HBV DNA in a HBsAg –ve person) [5]. Therefore, it is of utmost importance to carry out effective prophylactic strategies to prevent DNHB infection in children receiving HBcAb +ve grafts. Living related LT is an elective surgery, where the recipient, donor and surgical team have the chance for good preparation. Yet, it is not always easy to get a healthy suitable donor. We were faced by this problem in 2 of our pediatric patients, where the only available donors were healthy but were HBcAb +ve. One recipient was a case of homozygous familial hypercholesterolemia, a dominant trait carried by both parents and the other suffered from recurrent hepatoblastoma where intervention at the proper time was imperative.

On screening for hepatitis B virus infection in Egyptian blood donors negative for HBsAg, the prevalence of isolated HBcAb in tested samples was 13.3%. The overall prevalence of HBV DNA in healthy blood donors among isolated anti-HBc-positive individuals was 10% [6]. Our prophylactic regimen in management of recipients of HBcAb +ve grafts was similar to a great extent to that adopted by Tianjin First Central Hospital in China [7] but ours included preoperative booster doses of HBV vaccine targeting HBsAb titer above 1000 IU/L. Previous studies in both adult and pediatric HBcAb +ve liver graft recipients indicated that a preoperative HBsAb titer ≥1000 IU/L was effective in protecting recipients from HBV infection [8]. Lin, et al. reported 15.4% incidence of DNHB in patients whose HBsAb titers were between 100 and 1000 IU/L. No DNHB was seen in patients who’s anti‐HBsAb titers were kept above 1000 IU/L in that study [9]. This high titer would presumably neutralize the potential viral antigen coming from the HBcAb +ve grafts [10,11]. The high HBsAb titer that was attained preoperatively made it possible to use a lower intraoperative HBIg dose (50 IU/kg) than the one used in other studies [12,7]. In addition, a study in children indicated that the level of pre-LT HBsAb titer was associated with the response to post-LT booster vaccine [13].

Case no.1 successfully reached the pre-operative target titer of HBsAb, while case no.2 didn’t. As he had severe primary disease LT had to be performed although the target HBsAb titer was not reached. Our preoperative regimen provided the initial protection against DNHB infection, whereas the postoperative regimen provided a continuous protection as well as a salvage method for patients who did not meet the preoperative criterion. On the first year both children received a combination of HBIg and NUCs for one year aiming to maintain the HBsAb titer above 200 IU/L as postoperative HBsAb titer of <200 IU/L may increase the risk of DNHB [14]. The need to administer HBIg on long term is highly expensive, also the long-term use of lamivudine may raise the concern of mutant strains [5,15], so we shifted to active immunization with HBV vaccine starting from the second year post-LT. Because HBV vaccine response rates are lower in the early post-LT period, we used HBIg for maintenance of sufficient anti‐HBsAb levels during the first post-transplant year, when the level of immunosuppression is highest.

In the study of Park, et al. the median follow-up duration after vaccination was 26.5 months, and a median of 2.03 doses of vaccine per year was required for the maintenance of anti-HBs titers greater than at least 100 IU/l (4) while our patients were followed for 56 months in case 1 and 18 months in case 2, and only one double dose vaccine was required by each during the whole follow up period. Yoshizawa, et al. [16] reported that in the pediatric population post-LT double dose vaccination was effective in more than 80% of cases and a high titer of 1000 IU/L could be achieved even if pre-LT vaccination was not performed [16]. It is of not worthy to mention that in the first post-LT year, case 2 compared to case1 had a more rapid decay in HBsAb titer (1 month vs 3 months) and also needed more doses (7 doses) with higher HBsAb levels to maintain the target titer >200 IU/L. this may have been related to his immunosuppressed state specially that he received 2 chemotherapy cycles starting 1.5 months post-LT. Children treated for cancer are immunosuppressed during treatment and for a variable period after completion of chemotherapy. There is a reduction of vaccine-antigen specific antibody concentration for some time after the cessation of chemotherapy as chemotherapy is toxic for lymphocytes [17,18].

Early steroid withdrawal and low maintenance level of tacrolimus makes effective DNHB prophylaxis possible [19]. Steroid was considered to increase the risk of post-LT HBV infection as it may stimulate the glucocorticoid responsive element present in the viral genome thus further up regulating HBV gene expression [20]. Lifelong prophylaxis, continuous monitoring, and compliance are imperative for success of the prophylactic regimen. During the follow up period, HH and MA did not develop DNHB. Lifelong monitoring of HBV serologic status is necessary in these patients because DNHB has been known to occur late in the post-LT period [21]. probably due to development of escape mutants where there is loss of immunoreactivity against the variant despite presence of HBsAb.

Conclusion

Pre-operative vaccination with HBV vaccine targeting HBsAb titer >1000 IU/L followed by intra and post-operative HBIg supplementation combined with NUCs in the 1st post-LT year and switching to HBV vaccine thereafter was an effective prophylactic regimen against DNHB infection in our pediatric recipients receiving HBcAb +ve grafts. HBcAb +ve grafts can safely be used in pediatric LT if an adequate prophylactic regimen is followed.


For more Articles on: https://biomedres01.blogspot.com/

Tuesday, October 15, 2024

Natural H-Clinoptylolite in Synthesis & in Waste Water Treatment From of Acetoaminophen

 

Natural H-Clinoptylolite in Synthesis & in Waste Water Treatment From of Acetoaminophen

Introduction

Here is presented the results about the acylation of p-aminophenol adsorbed from an aqueous solution on H-clinoptilolite with acetic anhydride. It is known that the acylation of p-aminphenol is carried out with acetic anhydride or acetic acid chloride in acidic media [2,3]. It is assumed that a convenient reagent medium for this process is the use of heterogeneous acid catalytic systems based on aluminosilicates [2]. Nowadays natural zeolites are focused to applications in the sector of wastewater decontamination. There are many reasons for zeolites using in mentioned fields: good selectivity for many toxic cations and harmful compounds [4,5], as adsorbents for organic compounds [5]. Zeolites occur in nature in specific kinds of rocks. Zeolite rich rocks are widespread in Northern part of Armenia, occurring in much extended geological formations. The zeolite types are exclusively clinopilolite - in Idjevan / Northern-East of Armenia.

Discussion

Acylation proceeds by the mechanism of nucleophilic addition, in which the nitrogen atom of p-aminophenol as a nucleophile, attacking the carbonyl group of acetic anhydrides. An intermediate product is formed, which undergoes further elimination of the acetate anion. It is known that phenol is adsorbed better than aniline on the surface of H-zeolites. This probably also takes place during the deposition of aminophenol on the surface of the zeolite, thereby facilitating the reaction of chemioselective N-acylation of the free nitrogen atom in the molecule when reacting with acetic anhydride. A comparative analysis of the yield and reaction time during the synthesis of acetaminophen by the traditional method and by the method using H-zeolite as a heterogeneous catalyst was carried out. In the first case, the yield of paracetamol per hour is 86% [1], and when using the proposed method, 75% per hour. However, this method assumes that the reaction is carried out in the absence of a solvent, as well as the ease of isolating the reaction product. An optimal conditions have been established in order to isolate the product by means of a crystallization for improving the yield. The process of recrystallization of the product from an ethanol solution was also carried out to obtain a pure, white color of the synthesized acetaminophen. A study of the solvent system for thin-layer chromatography (TLC) of acetaminophen was also carried out. The most successful was the system of solvents - ethyl acetate: hexane - 1:1.

Kinetics Study for Acetaminophene Sorption on Zeiolites

In Figure 1 the adsorption of acetaminophene on zeolite depending of contact time is presented. It was obtained that the uptake of increases with the lapse of time. Absorption of acetaminophen is rapid in the first 100 minutes, after which the rate slows to equilibrium. The test results can be used to study the speed limit step.

biomedres-openaccess-journal-bjstr

Figure 1: Kinetics of acetaminophene adsorption on H-Clinoptilolite.

Experimental Part

Synthesis of acetaminophen was carried out on H-clinoptilolite. The progress of the reaction was monitored by thin layer chromatography (TLC), which was carried out on Silufol UV-254, and the development of trace substances was carried out in a desiccator saturated with iodine vapor. Gas-liquid chromatography was carried out on a GLC instrument, Cristall-2000 M, by using polar liquid phases DB-5 in the laboratory. Infrared (IR) spectra were recorded on a Specord IR 75 spectrophotometer. NMR spectra were recorded on a Varian USA Mercury Plus 〖NMR〗^1H spectrophotometer (300 MHz).

Preparation of Zeolites: Samples of natural zeolites - clinoptilolite and mordenite, previously crushed to sizes <10 mm, were subjected to grinding in a laboratory ball mill, then the crushed zeolites were subjected to sieve classification. Samples of natural zeolites purified from impurities were dried to constant weight at 105°C, a fraction of 0.25–0.5 mm was isolated by scattering, from which moisture was additionally removed at 350°C. Before weighing, the samples were kept in a desiccator over calcium chloride. Clinoptilolite was transferred to the H-form by treatment with 10% hydrochloric acid, at a ratio of T:L = 1:10 and room temperature (25°C), for 3 hours, then the zeolite was washed from acid on the filter until a negative reaction to the Cl- ion and dried.

Synthesis of Paracetamol by Acetylation of p-aminophenol on H-clinoptilolite: 11 g (0.1 mol) of p-aminophenol and 13 g (0.127 mol) of acetic anhydride pre-adsorbed on 25 g of H-clinoptilolite were stirred at room temperature in the absence of a solvent. The course of the reaction was monitored using a gas-liquid chromatograph ( GLCh - Crystal 2000M ). Heating in a boiling water bath lasted 1 hour. The mixture was extracted with CH2Cl2 (2×120 ml) and the organic layers were separated, washed with saturated NaHCO3 (2×150 ml) and water (100 ml) and dried over anhydrous MgSO4. Crystals began to form after filtering the solution. After separation of the crystals, the reaction mixture was filtered for separation the crystals. The filtrate was washed with cold water (+8, + 10˚C) and dried on filter paper. Then the filtrate was placed in a dryer /at a temperature of 100°C/. The resulting powder had a light pink color, so it was recrystallized in vacuo. Yield 11.34 g (75%) acetaminophen m.p. 167-170°C.

The identity of the product was confirmed on a gas-liquid chromatograph with a flame ionization detector under the following conditions: column, capillary column DB-5 (polydimethylsiloxane) for GC - size 0.30 m x 25 mm, Detector - FID; The mobile phase is nitrogen; column temperature 100°C; detector temperature 240°С; evaporator temperature 260°C. Retention time of paracetamol 2.40 min. The obtained crystals were dissolved in 70% ethanol (30 ml) for recrystallization. The solution was then heated to 60°C., then left to cool before bringing the temperature in the flask to room temperature, and again immersed in ice water for recrystallization. The crystallized solution was filtered and dried. The second time the crystals turned white. After recrystallization, 10.95 g (0.072 mol) of acetaminophen was isolated.

The identification of the obtained compound of the substance was carried out by joint thin-layer chromatography with the initial aminophenol. It was found:

1. Eluent ethyl acetate: hexane 1:1-Rf for acetaminophen is 0.62, Rf - 0.74 for p-aminaphenol,

2. Eluent chloroform: acetone 5:1-R for acetaminophen is 0.32, Rf is 0.50 for p-aminaphenol,

3. Eluent cyclohexane: acetone 1:1 - Rf for acetaminophen is 0.60, Rf is 0.82 for p-aminaphenol.

Identification of acetaminophen (paracetamol) was also carried out by a known method by GLC using polar liquid phases DB-5. IR spectrum, ν, cm-1: s 1660 - 1560 (aromatic ring, C=O, N-H), br 3325 - 3150 (N-H).

1H NMR spectrum, δ, ppm: 1.9 s (3H CH3), 6.70 (2H, Harom, J 8.2 Hz), 7.65 d (2H, arom, J 8.2 Hz), 9.15 s (1H OH), 9.70 br.s (1H NH).

Natural zeolites - clinoptilolite were dehydrated at 400oC in vacuum (0.1 mm) for 3-4 hours. H- clinoptilolite obtained by treatment natural clinoptilolite in HCL [5]. The removal of acetaminophen is carried out as follows. The researches were spent in static conditions on a laboratory rocking chair. H-Clinoptilolite brought in quantity of 1, 0 ± 0.01 g in water solutions, volume 100 ± 0.1 ml containing acetaminophen in quantity from the maximum solubility. Further a mix placed on a rocking chair and subjected to hashing during 6h., at temperature of 20oC, and then test defended within 24 h.

Conclusion

1. The possibility of synthesizing acetaminophen (paracetamol) from p-aminophenol adsorbed on H-clinoptilolite with acetic anhydride in the absence of a solvent has been established.

2. A convenient TLC solvent system was found to establish the identity of acetaminophen.

3. H-clinoptilolite show adsorption activity when paracetamol is removed from an aqueous solution.


For more Articles on: https://biomedres01.blogspot.com/

Monday, October 14, 2024

The Basics of Carbohydrate Periodization for Athletes and Coaches

 

The Basics of Carbohydrate Periodization for Athletes and Coaches

Introduction

The carbohydrate (CHO) periodization has been a potential strategy for which to amalgamate train-low paradigms and used for improving form store muscle glycogen and induce additional benefits on endurance athletes performance [1] as well as for elite football athletes [2] based on fueling for the athletes work required. These practices of initiating exercise with low muscle glycogen content has grown in popularity over recent years [3] and can show to professionals as a new way of prescribing diets for high performance athletes. Although, the used strategies lowering muscle glycogen through prolonged aerobic exercise with high fat low carb diet increases the metabolic importance on fat as a fuel source, while sparing carbohydrate during exercise [4]. there are still gaps need to be filled about how to apply a particular strategy to a athlete specific-type. When muscle glycogen content is low, fat oxidation is optimized, and nutritional guidance is to consume carbohydrate during prolonged exercise to sustain submaximal performance [5]. But, when low carb diet used for a prolonged period, around 15 days, the damage in the oxidation of carbohydrates is clear, even worsening insulin sensitivity of the athletes [6]. Therefore, aiming these unknowns regarding dietary prescription models of carbohydrate periodization strategies, athletes in general need a specific carbohydrate periodization strategy aligned with their personal and exercise profile, brought in this review to better target professionals when applying the strategies in practice.

The Mechanisms Behind Carbohydrate Periodization

The glycogen are particles distributed within the muscle cell to support the energy needs during exercise and are found roughly 75% located adjacent to the sarcoplasmic reticulum and mitochondria, 5 to 15% in contractile filaments as subsarcolemmal glycogen and other 5 to 15% are found between the sarcolemma and the contractile filaments [7]. The exercise makes the GLUT4 transporters move into the sarcolemma without the insulin assistance to aiding in glucose uptake. Simultaneously, glycogen degradation increases from exercise come in response to changes in the concentration of metabolites into the cell. Both molecules, those released from the blood and those released from glycogen itself are oxidized to produce the adenosine triphosphate (ATP) molecules required to sustain muscle contraction [7].

The exercise triggers mammalian target of rapamycin (mTOR) signaling [8]. Already exercising in reduced conditions CHO availability increases the lipolysis in adipose and intramuscular tissue by increased circulating adrenaline concentrations, wich generate fat free acids (FFA), which they will later interfere in the mTOR pathway creating adaptations that can optimize store future glycogen [9]. In addition, the consuming pre-exercise meals rich in CHO and / or CHO during exercise can downregulate lipolysis and reduce both AMPK and p38MAPK activity, thus having negative implications for downstream regulators [9]. In a way, the adaptations need to be well elaborated so that it can, in fact, induce new metabolic changes in the cell about the muscle glycogen storage.

In addition, the anabolic responses after exercise are regulated by the mTOR pathway too [10] and responses related to ATP generation are regulated by the AMP-activated protein kinase (AMPK) pathway [11] which is negatively regulated by glycogen availability and signaled in energy deficit and inhibit mTOR pathway [12]. In addition, the AMPK pathway responding to exercise intensity and acts as an intracellular signaler of energy status [13] besides conserving ATP content by activating catabolic signaling to restore cellular energy status [14] and to induce mitochondrial biogenesis in skeletal muscle [15]. Therefore, mTOR pathway which related to anabolic responses into the cell, undergoes changes when AMPK pathway is triggered by low energy availability and when there is a FFA greater intake by high fat diet or adrenaline induced by exercise. Although AMPK pathway is altered by CHO ingestion during exercise, both pathways, AMPK and mTOR, considering the FFA, need to be stimulated to adapt with strategies saving glycogen in low amounts of energy and subsequently potentiate the glycogen accumulation when in greater energy offerings.

The Carbohydrate Prescriptions Based on Exercise Time

The daily needs for fuel and recovery are based on training program and competitions. The amounts take into consideration exercise time, from low intensity or skill-based exercise to extreme exercise, which going to of 1 to 5 testing hours, respectively. For this, prescriptions can offer carbohydrate targets per kg of the player’s body weight, going to 3 – 5 g until 10 – 12 g per kg each day, basically [16]. Another more recent model of carbohydrate prescription for endurance athletes brought the same models previously mentioned [17]. And more recently, another work brought the same amounts, but with a focus on optimal glycogen stores before competition, using taper activity for 3 to 6 days combined with 36 to 48 hours before test offering 8 to 12 g carbohydrates per kg [18]. That is, both are in accordance with the quantities. However, the most recent academy position brought focus on the carbohydrate’s periodization at the before competition days. Another important fact is that the positions corroborate each other with carbohydrates offer before the competitions, with offering 1 to 4 g per kg eaten 1 to 4 hours before exercise [16-18].

Therefore, carbohydrate periodization prescribed based on the athlete’s exercise time and on his training and game schedule, should obey amounts of hours preceding the testing. Strategies such as “normal diet” or “classic glycogen loading” employ carbohydrates linear consumption end up not getting cannot reach an overcompensation of muscle glycogen stores. Therefore, carbohydrates periodization in days leading up to the competition has been shown a strategy that increase the muscle glycogen stores and a “modified” consumption in the carbohydrate load has been a good strategy for this, applying a consumption in week before the competition of 5 g per kg each day from sixth to fourth day and from 8 to 12 g per kg each day for past three days, in addition 24 hours rest prior to competition [19-21]. The “sleep low” strategy consists a week of training with high intensity workout and high carbohydrate availability on late afternoon for to deplete muscle glycogen, followed a sleeping with low carbohydrates availability but with proteins ingested and in next morning a low intensity workout in low carbohydrate availability but with carbohydrates supply during practice, all this to boost metabolic adaptations that improve fatty acids and carbohydrates oxidation and increase muscle glycogen storage after carbohydrate refeeding in rest of the day causing a better performance at the competition day in end of the week [22-24].

The “train low, compete high” strategy consists in train with reduced carbohydrates availability obeying the practical concept of “fuelling for the work required” so can compete with high carbohydrates availability, therefore being a potential strategy for to break train-low paradigms into periodized training programs with periodization carbohydrates strategies, turning this strategy into an interesting form of intervention to improve whole-body exercise capacity [25-27]. (Table 1) is a direct, summarized and referenced outline of the main practical applications of the carbohydrate periodization strategies with a description for better targeting when applying the athlete’s practical prescription.

biomedres-openaccess-journal-bjstr

Table 1: Compiled from the main carbohydrate periodization strategies.

Note: CHO, carbohydrates.

Conclusion

So, it is becoming complicated to assume a single strategy for one sport or even a single strategy for on athlete type. What is known is all strategies will have arguments for and against, will have seasons that better applicable and seasons that will not be able applied. This review brought recent and explanatory references with based on fundamentals behind the most used carbohydrate periodization strategies, as they are applied in practice and what strategy will benefit athlete’s performance. What is up to the coaches, together with their athletes, is to define which strategy is best applied for that season, and the strategies presented in this review demonstrate an improvement in the performance of endurance athletes.


For more Articles on: https://biomedres01.blogspot.com/

Wednesday, October 9, 2024

Trend of COVID-19 Suspected & Verified Cases Reported During 2020 at District Head Quarters Hospital Rawalpindi Pakistan

 

Trend of COVID-19 Suspected & Verified Cases Reported During 2020 at District Head Quarters Hospital Rawalpindi Pakistan

Introduction

Public health, food networks and numerous social and economic affairs are confronted with serious distressing challenges in response to COVID pandemic [1]. This life-threating outbreak posed a devastating risk not only to the physical health but also to psychological well-being of the individuals [2]. Governments of developing countries with limited testing capacity faced difficulty to tackle with overwhelming healthcare calamity [3]. Although spread of COVID-19 in Pakistan was determined to be quite sluggish [4]; however, some of the hospitals were still designated as COVID hospitals officially to facilitate the people amidst pandemic [5]. Despite the constrained resources laboratory testing kits, quarantine facilities were made freely available for convenience of the public and healthcare personnel in designated hospitals. Moreover, awareness sessions for acquaintance with the gravity of pandemic were periodically arranged due to novelty and nonfamiliarity with coronavirus [6].

Rapid spread of COVID-19 across the globe also provoked the lifestyle change [7]; however, prompt detection of infected cases and timely provision of intensive care can limit the dissemination of this menace [8]. In addition, guidance pertinent to contact tracing, social distancing, isolation, and quarantine were also propagated across the country by the government to prevent the overgrowth and spread of COVID-19 [9]. In a study carried out by Zeb S et al during 2020, most of the patients succumbing to COVID-19 at tertiary care hospital namely Holy Family Hospital, Benazir Bhutto Hospital and Rawalpindi Institute of Urology & Transplantation were reported to be above 50 years of age with pre-existing comorbidities mainly diabetes and hypertension [10]. Coupling of old age with immunodeficiency also subjected the victims to the ventilatory support [11]. Within 45 days of first coronavirus infected patient detection about 4,695 verified COVID-19 cases were determined across Pakistan and about 66 of these expired [12]. Despite the specification of COVID-19 suspected case criteria by WHO [13], data regarding COVID-19 suspects is quite ambiguous. The present study is therefore intended to determine the frequency of suspected as well as confirmed COVID-19 cases registered at DHQ Hospital during 2020. This study will facilitate the hospital administrators to make adequate arrangements for provision of patient care in the context of COVID-19.

Subjects & Methods

A cross-sectional descriptive hospital record-based study was done to explore the trend of COVID-19 at DHQ hospital during 2020. DHQ Hospital is a tertiary care hospital. It is located inside the Rawalpindi city and as is also affiliated with Rawalpindi Medical University for undergraduate and postgraduate medical education [14]. The data was gathered from hospital administrators through informed consent. Apart from verified COVID-19 cases, the data pertinent to suspects was also evaluated by using Microsoft Excel 2010.

Results

Of the total 1,908 COVID patients who visited DHQ Hospital during 2020, about 226 were confirmed COVID-19 cases while rest of the 1682 patients were categorized as suspected on PCR testing. The ratio of verified to suspects was computed to be 1:7.4. Monthwise reporting of COVID-19 cases at DHQ Hospital is illustrated below in Table 1. First confirmed COVID-19 case was registered at DHQ Hospital during May 2020 as depicted below in Figure 1. First suspected COVID-19 case was registered at DHQ hospital during February 2020. Trend of suspected COVID-19 cases and the maximum propensity was determined to be during December 2020 as illustrated below in Figure 2.

biomedres-openaccess-journal-bjstr

Table 1: Month-wise registration of suspected and confirmed COVID-19 cases at DHQ Hospital.

biomedres-openaccess-journal-bjstr

Figure 1: Trend of COVID-19 positivity at DHQ Hospital during 2020.

biomedres-openaccess-journal-bjstr

Figure 2: Trend of COVID-19 Suspects 2020 at DHQ Hospital.

Discussion

Uniqueness of coronavirus infection worldwide amidst COVID-19 pandemic was quite evident. In addition to communal flu-like clinical manifestations [15], the sufferers were also reported with varied dermatological [16] and neurological complaints [17]. Event this life endangering virus was determined to influence the care of neurological patients one way or the other [18]. Quarantine and isolation facilities in various provinces of Pakistan in addition to globally were made available amidst COVID pandemic in order to curtail the spread of coronavirus to other members of the community [19]. In our study, the ratio of confirmed to suspected COVID-19 cases is revealed as 1: 7.4. A suspected COVID-19 case was later declared as confirmed case by a local health department of Islamabad during March 2020. This case was attributed to participation in a religious congregation and contact with a foreign national over there [20]. On reviewing the comprehensive report of 72,314 COVID-19 cases from Chinese Center for Disease Control and Prevention, about 62% of these were categorized as confirmed due to positive nucleic acid test. While rest of the 22% and 15% were labeled as suspected and clinically diagnosed respectively due to history of exposure and clinical symptoms in addition to finding of coronavirus pneumonia as patients in these 2 categories could not be subjected to COVID testing. The remaining 1% of the case was devoid of COVID-related symptoms despite the positive report [21]. Lockdown was imposed in Pakistan on 1st April 2020 in order to restrict the spread of coronavirus infection [22]. Even with lockdown imposition in Pakistan in response to COVID pandemic, cases continued to rise swiftly (Figure 2) that ultimately rose steeply in June 2020 due to lifting of lockdown during Mid-May.

However, the ratio of confirmed to suspected COVID cases in reality pertinent to Pakistan as a whole can only be scrutinized by reviewing the record of cases from all the hospitals that were officially designated to manage the COVID cases. The suspected cases in current study were not subjected to PCR testing due to mild clinical manifestations. One of the reasons for this might be the limited opportunities provide by the government of Pakistan for COVID-19 testing [23]. A case control study carried out among 919 suspected cases during lockdown imposition in Portugal revealed COVID positivity only among 24.6% of the subjects. Moreover, only 27.1% of the people having history of contact with suspected or confirmed COVID -19 cases were disclosed as coronavirus infected on real time PCR testing [24]. A similar study by Chi Q et al among sixty-eight COVID-19 suspected cases revealed positivity only among 17 patients [25]. Novelty of coronavirus infection and broad spectrum of its clinical manifestations along with unpredicted resultant health outcome were chiefly responsible for substantial agitation among people; however further exploration by the scientists can lead to more clarification about this fatal virus.

Conclusion & Recommendations

Minimal proportion of COVID-19 confirmed cases was reported at DHQ Hospital during 2020 than those of suspected patients. However, strict observance of precautionary measures can be of great assistance in mitigation of suspects.


For more Articles on: https://biomedres01.blogspot.com/

Tuesday, October 8, 2024

Blood Flow Restriction Training in Osteoarthritis

 

Blood Flow Restriction Training in Osteoarthritis

Introduction

BFRT involves restricting blood flow to a targeted muscle group whilst making it perform movements under low load resistance. The aim of this is to achieve the same effect that putting the muscle through high resistance training (HRT) would accomplish. HRT is often not possible in certain patients due to cases involving injury or conditions such as osteoarthritis. In individuals without injury, there is already evidence that noteworthy improvements have been made to muscular hypertrophy, muscle fibre recruitment and endurance with BFRT (Takarada, et al. [1]). For healthy individuals, the American College of Sports Medicine recommends training with loads of 60–70% of their one repetition maximum (RM) for 8–12 repetitions to maximise muscular strength. However, for patients with knee pathology, performing movements with loads of 60–70% of their one RM may not be possible and could cause further injury (Buckthrope, et al. [2]). Quadriceps and hamstring muscles often atrophy with chronic osteoarthritis. The intention of using BFRT with patients is to reduce the level of atrophy and weakness in muscles caused [2,3]. For individuals over 60, osteoarthritis is the most common cause of disability. With a growing ageing population, osteoarthritis is likely to only increase in prevalence.

Many factors contribute to reduced function in patients with osteoarthritis; muscle weakness, especially in the quadriceps muscles, is a major cause of functional decline. The current advice is that patients with osteoarthritis can only participate in low to moderate load and intensity training. Due to the inability of these patients to engage with higher load or high-intensity training without associated knee pain or injury, BFRT is a valid alternative. The goal of BFRT is to increase skeletal muscle and strength without causing further injury or knee pain (Ferraz, et al. [3]). This literature review intends to give the reader an insight into the effectiveness of BFRT for osteoarthritis patients. This study will discuss several papers and relate whether the evidence suggests that BFRT can be used more widely in practice for knee osteoarthritis.

Methods

Search design: Studies were chosen following a comprehensive search of the PubMed database by independent researchers. The database was filtered to highlight studies that included the following in their title or abstract: ‘blood flow restriction’, ‘KAATSU’ or ‘blood flow occlusion’. To further narrow the search criteria and suit the objectives, search filters for ‘osteoarthritis’, ‘rehabilitation’, ‘lower limb’, ‘injury’ or ‘recovery’ were included with an ‘AND’ function. The database was searched from its inception until 1st October 2021. The studies selected for further discussion were ‘randomised controlled trials’ only. Literature reviews were also assessed to search for more trials to be used for comparison.

Design Rationale: ‘Randomised controlled trials’ were solely chosen for their ability to provide clear, objective outcomes, which, when pooled together, would provide data from which to draw significant conclusions. No time limit was placed on the trials used as, after consideration, each of the content was still deemed relevant to the objectives of the review.

Inclusion and Exclusion Criteria: After a review of the available literature, the following conditions were proposed for the study to be considered suitable:

(a) Randomised controlled trial or technical note;

(b) Primary focus on blood flow restriction training;

(c) A patient group comprising individuals using BFRT as a form of rehabilitation or recovery following osteoarthritis diagnosis; and

(d) Sole focus on lower limb and concentration on studies about osteoarthritis.

Limitations of the Methodology Used: Only the PubMed database was used to search for studies. Limiting to the abovementioned search criteria also restricted the number of studies available, hence reducing the significance of the review’s findings. The authors recognised this but deemed that it was more important to keep the aims of the review concise and coherent.

Studies Reviewed

Methods

A randomised controlled trial 3 conducted in Sao Paulo, Brazil, between 2011 and 2013 included women between 50–65 years of age with a diagnosis of knee osteoarthritis based on the criteria of the American College of Rheumatology. Exclusion criteria included a) Physical exercise training over the last year

b) Cardiovascular disease

c) Musculoskeletal issues preventing exercise engagement

d) Kellgren–Lawrence radiological assessment of 1 or 4 (Table 1)

e) Knee pain with a score of less than 1 or more than 8 on the visual analogue scale (Table 2)

f) Non-Steroidal Anti-inflammatory Drug (NSAID) use over the last three months; and

g) Intra-articular infiltration with hyaluronic acid and corticosteroids infiltration over the past six months. Fortyeight patients met the requirements to be included in the trial. Patients were asked to rate their knee pain on a scale of 1–10 on a visual analogue scale and were split into three groups according to their 1-RM weight for the leg press exercise.

They were then randomly allocated into one of the three groups:

1. High-intensity resistance training (HI-RT)

2. Low-intensity resistance training (LI-RT)

3. Low-intensity resistance training with BFRT [3]

biomedres-openaccess-journal-bjstr

Table 1: Kellgren–Lawrence radiological assessment.

biomedres-openaccess-journal-bjstr

Table 2: Visual analogue scale.

Patients were assessed at baseline and after 12 weeks of BFRT training relative to the HI-RT group. Their progress was measured based on the 1-RM leg press, knee extension, timed-stands test (TST), timed up and go test (TUG), quadriceps cross-sectional area and self-reported quality of life. The self-report was evaluated using a Short Form Health Survey (SF-36) and the Western Ontario and McMaster University Osteoarthritis Index (WOMAC) [3]. The women selected for this trial completed a twice-weekly resistance training exercise, which included bilateral leg press and knee extension, using strength training machines in a gymnasium. The LI-RT with BFRT group performed the exercises wearing an air cuff with a width of 175 mm and length of 920 mm that was placed at the inguinal fold and inflated to provide a pressure of 70% required for complete BFR. The restriction was maintained for all training sessions, including rest periods, and was immediately released after the session was complete. Cuff pressure was determined using a vascular doppler over the tibial artery that records the cuff pressure required at the inguinal fold for a complete loss of auscultatory pulse and then calculating 70% of that pressure [3]. The first-week training programme involved the HI-RT group performing four sets of 10 repetitions at 50% of their 1-RM. Comparatively, the LI-RT and LI-RT with BFRT groups performed four sets of 15 repetitions at 20% of their 1-RM.

From the second week onwards, the HI-RT group performed 80% of their 1-RM, while both the LI-RT and LI-RT with BFRT group’s intensity were increased to 30% of their 1-RM. After the fifth week, all groups raised the number of sets on both exercises from four to five. In between each set, all participants had a one-minute rest. Every four weeks, the participants’ 1-RM was reassessed, and the weight used for their training sets adjusted accordingly [3]. Based on the exclusion criteria, 48 patients were found for this study. They were divided equally into three groups, with 16 individuals per group. The HI-RT group had the most withdrawals at six, four of which were due to exercise-induced knee pain. Comparatively, the other two groups had fewer withdrawals, none of which was due to exercise-induced pain. Additionally, adherence to training protocols was 90% for HI-RT, 85% for LI-RT and 91% for BFRT [3]. Tests conducted to assess strength and functional movement: 1-RM for leg press and knee extension along with TST and TUG3. The TST records the number of times an individual can stand up from an armless chair, 45 cm in height, in 30 seconds. TUG tests record the time taken for a person to stand up from an armless chair, 45 cm in height, walk 3 metres, turn and return to the chair to sit down again. The patients in the study underwent familiarisation sessions for all tests so that learning rate did not affect the results.

Coefficients of variation for all tests were under 10%, suggesting that it is unlikely that other factors are the source of the variation (Table 3) shows within-group increases in 1-RM for leg press and knee extension in both the HI-RT and BFRT groups. For the HI-RT group, there was a 33% increase in the patients’ 1-RM leg press weight and 22% increase for their 1-RM knee extension. For the BFRT group, there was an increase of 26% and 23% for their 1-RM leg press and knee extension, respectively. Both groups showed a significant increase in 1-RM tests. However, there was no significant difference between the groups which were compared to each other after training [3]. In the case of the LI-RT group, their 1-RM leg press and knee extension increased by 8% and 7%, respectively. This growth was not significantly different, with P = 0.22 for the leg press and P = 0.23 for the knee extension. Significant improvements were seen in the HI-RT and BFRT groups for TST; with an increase of 14% for HI-RT and 7% for BFRT. Comparatively, the LI-RT group had no significant improvement with their 5% increase. Again, no significant differences were noted between the groups after training. For the TUG test, there were no significant differences noted either within or between the three groups after training [3]. The quadriceps cross-sectional area (CSA) was assessed using Computerized Tomography (CT) at the midway point between the greater trochanter and the lateral epicondyle of the femur by a researcher who was blinded to the treatment.

biomedres-openaccess-journal-bjstr

Table 3: Within-group increases in 1-RM for leg press and knee extension after 12 weeks of training.

Therefore, it is unlikely that there was any bias affecting the measurements. However, there are reasons other than an increase in muscle mass, which could be the cause of an increased crosssectional area [3]. For the post-training quadriceps CSA assessment, the results showed that there was a CSA increase in the HI-RT group by 8% and in the BFRT group by 7%. However, with an increase of 2%, there was no significant increase in the LI-RT group. It should also be noted that although the CSA increased within the groups, the groups were still not significantly different from each other after training (P > 0.05). Additionally, the HI-RT and LI-RT with BFRT groups were not significantly different, indicating that the two may be equally effective at increasing quadriceps CSA [3]. The WOMAC and SF-36 scales were used to assess pain and quality of life. The WOMAC scale is widely used in the evaluation of hip and knee osteoarthritis; it is divided into three subscales: pain, stiffness and physical function. The individual domains of each scale were recorded separately as can be seen in (Table 4). The table displays the changes in the WOMAC and SF-36 scores before and after training. The data shows the mean result for each category followed by the ± standard deviation 3. *P < 0.05 for within group comparisons [3]. For all groups, their scores in all WOMAC categories were similar before training and therefore comparable (P > 0.05).

After training, the WOMAC pain score was significantly lower for both the LIRT and BFRT groups as can be seen in (Table 4). There was a decrease in score by 45% in the LIRT group (Effect Size (ES) = –0.79, P = –0.001) and a decrease by 39% in the BFRT group (ES = –0.79, P = 0.02). Comparatively, the HIRT group only had a decrease of 31% (ES = –0.54, P = 0.19). The WOMAC stiffness score was significantly lower after training in the BFRT group [3]. BFRT was shown to be equally effective in improving strength as can be seen by the within-group increases in 1-RM for leg press and knee extension after 12 weeks of training. The TST showed that HI-RT and BFRT were both effective. However, there was no significant difference in the TUG test score, suggesting that there is a potential for BFRT to aid with functionality in osteoarthritis patients. BFRT appears to be equally effective as HIRT at improving quadriceps CSA. The WOMAC scores indicate that BFRT would be preferred over HIRT to reduce pain and improve quality of life. However, there was no difference in the SF-36 [3]. As can be seen from the above results, BFRT is equally successful in improving strength and function and increasing muscle mass to prevent atrophy whilst causing much less pain or discomfort to the patient than HIRT. As the study excludes patients who scored 1 or 4 on the Kellgren– Lawrence scale, it cannot be argued that the same results will be achieved for all patients with osteoarthritis, especially those with a score of 1 and with mild osteoarthritis or those with a score of 4 and with severe osteoarthritis.

biomedres-openaccess-journal-bjstr

Table 4: Changes in Scores for WOMAC and SF-36 scales before and after training.

Although, those with a score of 4 will not be able to perform the activity required for this training [3]. Another disadvantage is that VAS, SF-36 and WOMAC are self-assessments; due to the nature of how arterial occlusion is obtained, participants will know when they are in the BFRT group. Additionally, only woman of a specific age range are included in this trial; thus, it is unclear if the same findings will occur in men or women outside the age range of 50–65, especially when numerous patients with osteoarthritis are older than 65. There is also the possibility that other medications taken by the patients could either positively or negatively affect their performance and skew the results. Furthermore, only a small sample size (48 patients) was used in this study. In the future, a study with a larger and more diverse population would need to be used to better determine the efficacy of BFRT. Despite its small sample size, this study showed that BFRT has similar efficacy in improving lower limb strength, quadriceps cross-sectional area and knee function as HI-RT. BFRT also presented greater improvement in WOMAC scores relative to HI-RT. Moreover, there were substantially fewer patients in the BFRT group who withdrew from the study. All of these suggest that BFRT could be used as a possible substitute for HI-RT in patients with osteoarthritis; thus, they do not need to undergo vigorous exercises that can cause pain, and yet still achieve positive muscular changes [3].

In Florida (USA), in a pilot randomised clinical trial of 35 patients with symptomatic knee osteoarthritis causing physical limitations, the patients performed 12 weeks of lower limb training comparing BFRT against moderate-intensity resistance training (MIRT). The study assessed changes in physical function, muscular strength and pain. There were 16 patients who undertook BFRT and 19 patients who did MIRT. The study’s aim was to assess the safety and effectiveness of BFRT for improving muscular strength in symptomatic older adults with knee osteoarthritis (Harper, et al [4]). Inclusion criteria required patients to be over 60 years of age, have objective functional limitations, not be partaking in regular resistance training and have symptomatic knee osteoarthritis. Exclusion criteria included contraindications to tourniquet use (such as peripheral vascular disease), a systolic blood pressure of over 160 or under 100 mm Hg and absolute contraindications to the training or medical conditions that deemed it unsafe. Patients were deemed to have osteoarthritis if they had radiographic evidence of osteophytes, scored > 0 on the graded chronic pain scale and had a Kellgren–Lawrence grade ≥ 2 for the affected knee on a bilateral standing anterior–posterior radiograph. Thirty-three patients completed the study; one patient from the BFRT group and one from the MIRT group withdrew their consent to continue.

Three patients from each group (six total) stopped further participation during the training phase but decided to remain in the trial. A total of 81.4% of patients adhered fully to the BFRT training regime and 83.0% adhered fully to the MIRT training regime. This suggests that BFRT is tolerated well by osteoarthritic patients, suggesting that continued use of BFRT should not be an issue for patients when compared to MIRT [4]. There were 14 reports of knee pain that seemed likely or possibly related to the training regimes. Three of these occurrences were reported in the BFRT group and 11 were in the MIRT group. The study suggests that there were two serious adverse events in the BFRT group, with just one of these events related or potentially related to the study; there were three serious adverse events in the MIRT group. However, the study does not expand on what deemed these adverse events to be classified as serious or what led them to believe it was related to the training. These are important points to note as the goal is to keep pain to a minimum whilst still increasing strength [4]. The training in both groups involved supervised resistance exercise training three times a week. After a warmup, patients performed lower body strength training followed by flexibility and balance training. Standard isotonic resistance training equipment was used for the resistance exercises. The lower limb exercises included leg press, leg extension, leg curl and calf extension.

Participants underwent a familiarisation session prior to the start of the official training. This was to ensure they were using proper techniques for the exercises and so they could become accustomed to the machines used. Starting weights were determined by establishing each patients’ one-repetition maximum (1-RM) for leg press, leg extension, leg curl and calf extension. At the last session of the third, sixth, ninth and twelfth week, the participants’ 1-RM was remeasured. The weight required for participants to use in their training was then recalculated [4]. In the MIRT group, the resistance exercises mentioned were performed at 60% of the patients’ 1-RM. The BFRT group performed the resistance exercises at 20% of their 1-RM but with compression applied at the patients’ proximal thighs using pneumatic cuffs. The cuff pressure for each participant was calculated with the equation:

Cuff pressure = 0.5 (systolic blood pressure) + 2 (Thigh circumference) + 5

The restriction was sustained throughout each training exercise including rest times between sets. However, the cuff restriction was alleviated for the rest period when switching from one exercise to another. All exercises were performed to volitional fatigue. The issue with this is that the number of repetitions and effort put in by patients differs on an individual basis, which could have had an effect on the level of improvement [4].

Patients’ improvement was assessed using several tools and questionnaires. These included:

 Dynamometer to assess torque/strength.

 Timed walking speed over 400 m (ten laps of a 40 m course).

 Visual analogue scale (VAS) used immediately after walking 400 m to assess patients’ current pain.

 Western Ontario and McMaster Universities Arthritis Index (WOMAC) to measure pain related to the knees.

 Short Physical Performance Battery (SPPB) to assess lower limb physical function. The patient is asked to perform several tests to assess physical function including balance tests, the gait speed test and the chair stand test. A score is calculated out of 12 with a higher score suggesting better physical function.

 The disability component of the Late Life Function and Disability Instrument (LLFDI). The LLFDI (disability component) aims to self-assess physical function using 16 questions to assess frequency of task performance and perceived limitations to provide good indicators of the patient’s level of disability. The questions establish how often a patient performs an activity as well as the extent to which they feel limited while doing the activity. Scores are recorded on a scale of 0–100 (recorded separately for frequency and limitation) with higher scores suggesting better physical function [4].

The results below are shown with 95% confidence intervals in brackets for the mean differences reported in this study. Using the dynamometer, the mean change calculated using both groups after undergoing training for knee extensor peak torque at 60 degrees, 90 degrees and 120 degrees was found to be 9.96 (5.76, 14.16) Nm. The mean change between groups at 12 weeks for mean composite knee extensor peak torque when comparing BFRT to MIRT was 1.87 (−10.96, 7.23) Nm less. Therefore, we can say that knee extensor strength improved for both groups over the 12-week period. However, MIRT appears to improve knee extensor power (torque) more than BFRT [4]. The mean change calculated using both groups in the 400 m walk gait speed test was a reduction of 0.03 (−0.08, 0.01) m/s. The post-training change between groups for the 400 m walk gait speed test was a reduction of only 0.01 (−0.11, 0.09) m/s (BFRT compared to MIRT), suggesting both training methods are equally non-effective at improving gait speed based on this test [4]. The mean change to the SPPB calculated using both groups after undergoing training was an increase of 0.47 (−0.03, 0.97) points. However, post-training, the score for BFRT was 0.66 (−1.74, 0.42) points less than for MIRT. Considering that the maximum possible score for the SPPB is 12 and the minimum 0, a difference of 0.66 points would not be considered to validate MIRT as significantly better than BFRT for improving physical performance [4].

The mean change calculated using both groups for the frequency total for the LLFDI after undergoing training was −0.14 (−2.23, 1.94) points. Comparing points after training between groups showed that BFRT had 0.79 less points than MIRT. This shows that neither group was particularly successful at improving physical function upon self-assessment. Although BFRT seems to have negatively affected the LLFDI score post-training, the difference of 0.79 (−6.76, 5.17) points between BFRT and MIRT is so small on a scale of 0–100 that it does not seem significant [4]. The mean change calculated using both groups for the limitation total for the LLFDI after undergoing training was 4.36 points (0.06, 8.72). Comparing points after training between groups showed that BFRT had 6.60 (−18.99, 5.79) points less than MIRT. This shows that MIRT was superior to BFRT in improving the limitation total for the LLFDI score. The mean change calculated using both groups for the WOMAC pain scale was a decrease of 0.81 (−2.04, 0.42). Comparing points after training between groups showed that BFRT had 0.24 (−2.51, 2.98) points more than MIRT. However, given this small difference, we cannot say that BFRT causes less knee pain than MIRT [4]. The mean change calculated using both groups for total lean mass before and after training was 0.40 kg (−0.61, 1.40). Comparing points after training between groups showed that BFRT had 1.10 kg less than MIRT.

This suggests that MIRT is more effective at increasing lean mass than BFRT [4]. The mean change calculated using both groups for change in lower lean body mass was 0.71 kg (1.07, 0.36). Comparing points after training between groups showed that the BFRT group had gained a mean of 0.44 kg (−1.26, 0.39) less than the participants in the MIRT group. This suggests that although BFRT aided an increase in lower lean body mass, it was not as effective as MIRT. The mean change calculated using both groups for total body fat percentage was a decrease of 1.02%. Comparing points after training between groups showed that the participants in the BFRT group had a mean total body fat 1.12% more than the MIRT group. However, it is not mentioned in the study which method was used to calculate the lean mass – total body fat percentage or lower lean body mass [4]. As being overweight is a risk factor for osteoarthritis, it would seem beneficial for patients to undergo the training regime that causes the most weight loss. However, it should be noted that weight loss will not be a goal for all patients as some may already be underweight or have other medical conditions causing weight loss. In this pilot study, it does not appear that BFRT is any better than MIRT at reducing body fat or increasing lean muscle mass. The results show that BFRT is a safe alternative to MIRT to improve pain and function in older osteoarthritic patients; however, this should not be over-analysed as it is a pilot study with a small number of participants. From the results above, it does not seem that BFRT is more effective than MIRT; indeed, many of the tests, such as the limitation total for LLFDI and knee extensor peak torque, suggest that MIRT shows a better outcome. A larger scale randomised control trial will be required to fully ascertain if BFRT is an alternative to MIRT [4].

Discussion

Both studies looking at BFRT in patients with osteoarthritis over a course of 12 weeks showed that BFRT was a safe and effective way to improve function and strength when compared to HIRT or MIRT, whilst limiting pain caused to the patient. However, these are both small studies: one has 48 patients with an age range of 50–65 years [3] and the other had 35 patients with a mean age of 67.2 years4. The 2019 Harper et al. study was only a pilot clinical trial; larger scale studies with a wide age range and for a longer period of time will need to be conducted to fully verify how effective BFRT is at improving function and strength in those with osteoarthritis. The efficacy of using BFR post-knee surgery and for osteoarthritis is uncertain as there is a scarcity of studies and the application of BFR often differs, for example, in regard to limb occlusion pressures, the timing of the initiation of BFR, the frequency of exercise and the angle at which certain exercises are performed with BFR. In the studies mentioned above, the training methods and use of BFR varied, making it difficult to directly compare the effectiveness of BFR. For example, when we compare the training methods used in each of the osteoarthritis studies, they show differences in the exercises used, the frequency of training per week, the occlusion pressures used, the number of repetitions per set and the time at which 1-RMs are reassessed. We believe that the advantages of being able to reduce muscle atrophy and improve muscle strength for individuals with osteoarthritis using only low-resistance exercises outweigh the risks of using BFR, especially as many of the risks associated with BFR can be reduced with the recommended tourniquet equipment and proper application of the devices (De Phillipo, et al. [5]).

Conclusion

BFRT when used correctly has the potential to prevent muscle atrophy as well as improving muscle strength for patients who have knee osteoarthritis. Using standardised training programmes with similar methods for acquiring occlusion would allow for direct comparison of studies against each other and help to identify whether BFRT is truly an intervention that will produce positive results. Further research with larger cohorts of patients is required to fully assess whether BFRT is a valid alternative to improve strength and function and reduce atrophy in patients with knee osteoarthritis. If further evidence supports the findings found in this paper then BFRT should be used more widely in practice for patients with osteoarthritis.


For more Articles on: https://biomedres01.blogspot.com/

De Novo Hepatitis B Prophylaxis in Pediatric Recipients of Hepatitis B Core Antibody-Positive Living Donor Liver Grafts

  De Novo Hepatitis B Prophylaxis in Pediatric Recipients of Hepatitis B Core Antibody-Positive Living Donor Liver Grafts Introduction Liver...